Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation
Aldo Bonaventura, Alessandra Vecchié, Lorenzo Dagna, et al.
Inflammation Research (2022) Vol. 71, Iss. 3, pp. 293-307
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications
Nicola Potere, Marco Giuseppe Del Buono, Roberto Caricchio, et al.
EBioMedicine (2022) Vol. 85, pp. 104299-104299
Open Access | Times Cited: 80
Therapeutic potential of PANoptosis: innate sensors, inflammasomes, and RIPKs in PANoptosomes
Ankit Pandeya, Thirumala‐Devi Kanneganti
Trends in Molecular Medicine (2023) Vol. 30, Iss. 1, pp. 74-88
Open Access | Times Cited: 76
Apolipoprotein C3 (ApoC3) facilitates NLRP3 mediated pyroptosis of macrophages through mitochondrial damage by accelerating of the interaction between SCIMP and SYK pathway in acute lung injury
Zhichen Pu, Wenhui Wang, Haitang Xie, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111537-111537
Closed Access | Times Cited: 19
Traditional herbs against COVID-19: back to old weapons to combat the new pandemic
Hayder M. Al‐kuraishy, Omnia Momtaz Al-Fakhrany, Engy Elekhnawy, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 55
The Potential Role of Growth Differentiation Factor 15 in COVID-19: A Corollary Subjective Effect or Not?
Ahmad O. Babalghith, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Diagnostics (2022) Vol. 12, Iss. 9, pp. 2051-2051
Open Access | Times Cited: 45
The effects and mechanisms of the anti-COVID-19 traditional Chinese medicine, Dehydroandrographolide from Andrographis paniculata (Burm.f.) Wall, on acute lung injury by the inhibition of NLRP3-mediated pyroptosis
Zhichen Pu, Bangzhi Sui, Xingwen Wang, et al.
Phytomedicine (2023) Vol. 114, pp. 154753-154753
Open Access | Times Cited: 25
Regulation and functions of the NLRP3 inflammasome in RNA virus infection
Zhaoyang Yue, Xuelong Zhang, Yu Gu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 13
Open Access | Times Cited: 12
Ferroptosis and pyroptosis signatures in critical COVID-19 patients
Cédric Peleman, Samya Van Coillie, Symen Ligthart, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 9, pp. 2066-2077
Open Access | Times Cited: 20
The double sides of NLRP3 inflammasome activation in sepsis
Clara Vigneron, Bénédicte F. Py, Guillaume Monneret, et al.
Clinical Science (2023) Vol. 137, Iss. 5, pp. 333-351
Closed Access | Times Cited: 18
Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects
Е. Л. Насонов
Rheumatology Science and Practice (2024) Vol. 62, Iss. 1, pp. 32-54
Open Access | Times Cited: 7
NLRP3 Inflammasomes: Dual Function in Infectious Diseases
Yanbo Li, Rui Qiang, Zheng-Min Cao, et al.
The Journal of Immunology (2024) Vol. 213, Iss. 4, pp. 407-417
Closed Access | Times Cited: 7
Effect of increasing doses of colchicine on the treatment of 333 COVID‐19 inpatients
Rumen Tiholov, A Lilov, Gergana Georgieva, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 5
Open Access | Times Cited: 6
Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
John W. Eikelboom, Sanjit S. Jolly, Emilie P. Belley‐Côté, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 12, pp. 1169-1177
Open Access | Times Cited: 25
The multifaceted roles of NLRP3-modulating proteins in virus infection
James Harris, Natalie A. Borg
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
Colchicine in Athero-Thrombosis: Molecular Mechanisms and Clinical Evidence
Giovanni Cimmino, Francesco S. Loffredo, Gennaro De Rosa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2483-2483
Open Access | Times Cited: 12
Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients
Natália B. do Amaral, Tamara Silva Rodrigues, Marcela C Giannini, et al.
Inflammation Research (2023) Vol. 72, Iss. 5, pp. 895-899
Open Access | Times Cited: 11
Alkaloids Derived from Tyrosine: Phenethylisoquinoline (Colchicine)
Mihir Halder, Pijush Paul, Sumita Jha
Springer eBooks (2025), pp. 1-36
Closed Access
Cognitive Sequelae of COVID‐19: Mechanistic Insights and Therapeutic Approaches
Yuhao Chen, Jing‐Shiun Jan, Chih‐Hao Yang, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 3
Open Access
Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
John W. Eikelboom, Sanjit S. Jolly, Emilie P. Belley‐Côté, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 12, pp. 1160-1168
Open Access | Times Cited: 18
Effect of an Accidental Colchicine Overdose in a COVID-19 Inpatient With Bilateral Pneumonia and Pericardial Effusion
Tsanko Mondeshki, Radoslav Bilyukov, Vanio Mitev
Cureus (2023)
Open Access | Times Cited: 10
Differential activation of programmed cell death in patients with severe SARS-CoV-2 infection
Ashleigh N. Riegler, Paul V. Benson, Kenneth D. Long, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Redox Regulation of Nucleotide-Binding and Oligomerization Domain-Like Receptors Inflammasome
Francesca Ferrara, Alessandra Pecorelli, Giuseppe Valacchi
Antioxidants and Redox Signaling (2023) Vol. 39, Iss. 10-12, pp. 744-770
Closed Access | Times Cited: 8
A Selective Review and Virtual Screening Analysis of Natural Product Inhibitors of the NLRP3 Inflammasome
Sherihan El‐Sayed, Sally Freeman, Richard A. Bryce
Molecules (2022) Vol. 27, Iss. 19, pp. 6213-6213
Open Access | Times Cited: 13
Synthesis of conjugates of (aR,7S)-colchicine with monoterpenoids and investigation of their biological activity
Ekaterina S. Shchegravina, Sofia D. Usova, Dmitry S. Baev, et al.
Russian Chemical Bulletin (2023) Vol. 72, Iss. 1, pp. 248-262
Open Access | Times Cited: 7
Treatment with COLchicine in hospitalized patients affected by COVID-19: The COLVID-19 trial
Carlo Perricone, Mirko Scarsi, Antonio Brucato, et al.
European Journal of Internal Medicine (2022) Vol. 107, pp. 30-36
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top